Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
2024年3月13日 - 5:50AM
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an
innovative life sciences technology company providing mission
critical automation solutions to facilitate the efficient
manufacturing and fast, safe release of healthcare products, today
announced that the Company will participate in the virtual KeyBanc
Life Sciences & MedTech Investor Forum on March 19, 2024.
Rob Spignesi, President and CEO, and Sean
Wirtjes, CFO, are scheduled to participate in a question-and-answer
session with the host analyst on Tuesday, March 19, 2024, at 12:00
p.m. Eastern Time. This presentation time has been updated from the
Company’s previously announced schedule.
A live webcast of the presentation will be
available on the Rapid Micro Biosystems investor relations website
at https://investors.rapidmicrobio.com/ and can be accessed here.
The webcasts will be archived and available for replay after the
event.
About Rapid Micro
Biosystems
Rapid Micro Biosystems is an innovative life
sciences technology company providing mission critical automation
solutions to facilitate the efficient manufacturing and fast, safe
release of healthcare products such as biologics, vaccines, cell
and gene therapies, and sterile injectables. The Company’s flagship
Growth Direct System automates and modernizes the antiquated,
manual microbial quality control (“MQC”) testing workflows used in
the largest and most complex pharmaceutical manufacturing
operations across the globe. The Growth Direct System brings the
quality control lab to the manufacturing floor, unlocking the power
of MQC automation to deliver the faster results, greater accuracy,
increased operational efficiency, better compliance with data
integrity regulations, and quicker decision making that customers
rely on to ensure safe and consistent supply of important
healthcare products. The Company is headquartered and has U.S.
manufacturing in Lowell, Massachusetts, with global locations in
Lexington, Massachusetts, Switzerland, Germany, and the
Netherlands. For more information, please
visit www.rapidmicrobio.com or follow the Company on
Twitter at @rapidmicrobio or on LinkedIn.
Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
mbeaulieu@rapidmicrobio.com
Media Contact:
media@rapidmicrobio.com
Rapid Micro Biosystems (NASDAQ:RPID)
過去 株価チャート
から 1 2025 まで 2 2025
Rapid Micro Biosystems (NASDAQ:RPID)
過去 株価チャート
から 2 2024 まで 2 2025